An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth

Vania Vidimar, Greg L. Beilhartz, Minyoung Park, Marco Biancucci, Matthew B. Kieffer, David R. Gius, Roman A. Melnyk*, Karla J.F. Satchell

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth'. Together they form a unique fingerprint.

Medicine & Life Sciences